NCT04301076 2026-03-18
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
Phase 1 Suspended
Clinical Trials
8 trialsNCT05237245 2025-11-20
HTLV-OBS
Assistance Publique - Hôpitaux de Paris
Recruiting
NCT02631746 2025-03-14
Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT03226119 2018-09-13
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
MP Biomedicals, LLC
Phase 4 Completed
NCT00854581 2018-04-17
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
University of Miami
Phase 4 Terminated
NCT00001156 2017-07-02
Assessment of Patients With Multiple Sclerosis (MS)
National Institutes of Health Clinical Center (CC)
Completed
NCT03146013 2017-06-12
Dual Algorithm Post Market Clinical Study
MP Biomedicals, LLC
Completed
NCT01467024 2011-11-08
Evaluation of the MP Diagnostics HTLV Blot 2.4
MP Biomedicals, LLC
Unknown